Literature DB >> 16305072

RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study.

Clair M Sullivan1, T Simon Futers, Jennifer H Barrett, Barry I Hudson, Mark S Freeman, Peter J Grant.   

Abstract

UNLABELLED: Activation of the receptor for advanced glycation end-products (RAGE) leads to a cascade of pro-inflammatory and pro-coagulant responses which are important in the pathogenesis of the vascular complications of diabetes mellitus. It is known that pro-inflammatory mechanisms underpin the development of type 2 diabetes. Our hypothesis is that RAGE may be involved in the evolution of insulin resistance in addition to mediating glucotoxic complications of diabetes mellitus.
METHODS: To investigate the relationship between RAGE allelic variation and insulin resistance, the Gly82Ser variant and three promoter variants (-429, -374, 63 bp deletion) were studied in 480 subjects of known relationship from 89 families characterised for insulin resistance (using homeostasis model assessment [HOMA]) and for atherothrombotic risk. Carriage of the -429 C allele was weakly associated with increased insulin resistance (p = 0.02) when pedigree analysis was performed using SOLAR software.
RESULTS: Insulin resistance was estimated to have a heritability of 25.8% before the addition of covariates. Analysis of the relationship between RAGE and insulin resistance indicated that the -429 polymorphism reduced the unexplained heritability of insulin resistance after adjusting for covariates (age, sex, body mass index) from 17.5% of the total variance to 15.6% of the total variance.
CONCLUSIONS: These preliminary results indicate that the RAGE gene may affect the development of insulin resistance or be in linkage disequilibrium with a locus involved in this process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305072     DOI: 10.3132/dvdr.2005.005

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  11 in total

1.  Shared Genetic Control of Brain Activity During Sleep and Insulin Secretion: A Laboratory-Based Family Study.

Authors:  Lisa L Morselli; Eric R Gamazon; Esra Tasali; Nancy J Cox; Eve Van Cauter; Lea K Davis
Journal:  Diabetes       Date:  2017-10-30       Impact factor: 9.461

2.  Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.

Authors:  A P Gjesing; C T Ekstrøm; H Eiberg; S A Urhammer; J J Holst; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2012-02-15       Impact factor: 10.122

3.  Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.

Authors:  Radana Gurecká; Ivana Koborová; Melinda Csongová; Jozef Šebek; Katarína Šebeková
Journal:  Glycoconj J       Date:  2016-06-14       Impact factor: 2.916

4.  Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.

Authors:  J M Forbes; J Söderlund; F Y T Yap; M Knip; S Andrikopoulos; J Ilonen; O Simell; R Veijola; K C Sourris; M T Coughlan; C Forsblom; R Slattery; S T Grey; M Wessman; H Yamamoto; A Bierhaus; M E Cooper; P-H Groop
Journal:  Diabetologia       Date:  2011-02-06       Impact factor: 10.122

5.  Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.

Authors:  Sonya J Elder; Alice H Lichtenstein; Anastassios G Pittas; Susan B Roberts; Paul J Fuss; Andrew S Greenberg; Megan A McCrory; Thomas J Bouchard; Edward Saltzman; Michael C Neale
Journal:  J Lipid Res       Date:  2009-04-16       Impact factor: 5.922

Review 6.  Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.

Authors:  Magdalena Pertynska-Marczewska; Zaher Merhi
Journal:  Reprod Sci       Date:  2014-09-16       Impact factor: 3.060

Review 7.  Soluble forms of RAGE in internal medicine.

Authors:  Natale Vazzana; Francesca Santilli; Chiara Cuccurullo; Giovanni Davì
Journal:  Intern Emerg Med       Date:  2009-09-02       Impact factor: 3.397

8.  Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma.

Authors:  Ling Zeng; Juan Du; Wei Gu; An-qiang Zhang; Hai-yan Wang; Da-lin Wen; Lin Qiu; Xue-tao Yang; Jian-hui Sun; Mao Zhang; Jiang Hao; Jian-xin Jiang
Journal:  Crit Care       Date:  2015-01-09       Impact factor: 9.097

9.  Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus.

Authors:  Subrata Kumar Biswas; Sabreena Mohtarin; Sonchita Rani Mudi; Taznuva Anwar; Laila Anjuman Banu; Sheikh Md Khorshed Alam; Md Fariduddin; M Iqbal Arslan
Journal:  J Diabetes Res       Date:  2015-05-19       Impact factor: 4.011

10.  Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study.

Authors:  Haruki Momma; Kaijun Niu; Yoritoshi Kobayashi; Cong Huang; Masahiko Chujo; Atsushi Otomo; Hiroko Tadaura; Toshio Miyata; Ryoichi Nagatomi
Journal:  Diabetol Metab Syndr       Date:  2014-03-06       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.